Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$524,358,144
+$43,845,570 QoQ
Shares Held
2,064,646
+5.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#96
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $2,885,207,124 across 10 Drug Manufacturers - General names. JNJ ranks #2 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
895,262 | $1,073,804,190 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,064,646 | $524,358,144 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,364,831 | $432,380,783 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,940,617 | $245,177,551 | |
| 5 | ABBV |
AbbVie Inc.
|
861,436 | $216,771,755 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
2,865,663 | $165,119,502 | |
| 7 | PFE |
Pfizer Inc
|
5,127,377 | $123,467,238 | |
| 8 | AMGN |
Amgen Inc
|
236,929 | $85,796,729 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $524,358,144 | 2,064,646 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $480,512,574 | 1,965,769 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $439,977,562 | 2,126,009 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $459,532,134 | 2,478,331 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $387,372,778 | 2,535,992 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $410,683,356 | 2,476,383 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $255,690,907 | 1,768,019 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $295,634,389 | 1,824,228 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $270,990,578 | 1,854,068 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $312,033,413 | 1,972,523 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $361,721,593 | 2,307,781 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $481,373,721 | 3,090,682 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $659,223,786 | 3,982,744 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $682,584,970 | 4,403,774 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $801,050,692 | 4,534,677 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $774,581,078 | 4,741,559 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $845,241,201 | 4,761,654 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $760,180,055 | 4,289,229 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $546,281,252 | 3,193,320 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $436,445,352 | 2,702,448 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $499,774,703 | 3,033,718 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $524,248,724 | 3,189,831 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $530,704,402 | 3,372,121 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $465,901,796 | 3,129,378 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $501,068,346 | 3,563,026 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $572,148,907 | 4,363,219 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||